The global parenteral nutrition market size is expected to
reach USD 8.26 billion by 2026, according to a new report by Grand View
Research, Inc., progressing at a CAGR of 5.8% during the forecast period.
Increasing rate of natality and surging geriatric population is fueling the
market growth.
As of 2014, the natality rate reported by the
National Center for Health Statistics (NCHS) is 12.5 births per 1,000
populations in U.S. Furthermore, the percentage of lower weight infants was
8.0%, thereby boosting the demand for parenteral nutrition products in the
country.
The realized natality is rising over the last
decade and is anticipated to sustain growth over the forecast period. However,
in 2011, a dip was witnessed in U.S. owing to alteration in fertility rate of
the local female population. However, in the same year, hike in the number of
births for foreign based immigrant citizens was also observed leading to an
overall rise in birth rate.
Moreover, a large number of premature babies
suffer from low weight as well as undeveloped immunity thus putting them at
risk. Parenteral nutrition reduces the risk of infection and underdevelopment,
thereby promoting its application.
As per the National Center for Healthcare
Statistics, the premature birth rate of the U.S. is about 9.6% as of 2016, and
the national authorities are working to reduce it to 8.1%.
In very low birth weight (VLBW) newborns,
demand for parenteral nutrition is higher owing to low prospect of enteral
nutrition. Hence, use of parenteral nutrition in premature infants results in
improved intrauterine nutrient deposition, faster neurological development, and
minimized risk of complications thus improving their chances for survival.
Browse full research report on Parenteral
Nutrition Market:
https://www.grandviewresearch.com/industry-analysis/parenteral-nutrition-market
Further key
findings from the study suggest:
- Single dose amino acid solution segment
dominated the market in 2018 owing to increasing use of amino acid
solutions that possess fewer side effects thus enhancing patient benefits
- North America led the market in terms of
revenue and accounted for 41.73% of the overall share in 2018. Presence of
high research expenditure by private entities and government agencies in
the healthcare sector and collaborations among medical device industry,
regulatory authorities, and universities are responsible for the market
growth
- Some of the companies present in the
parenteral nutrition market are B. Braun Melsungen AG; Baxter
International, Inc.; Fresenius Kabi AG; Hospira, Inc.; Actavis, Inc.;
Grifols International S.A.; Otsuka Pharmaceutical Factory, Inc.; and
Sichuan Kelun Pharmaceutical Co. Ltd.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/parenteral-nutrition-market/request/rs1
Grand
View Research has segmented the global parenteral nutrition market based on
nutrient type and region:
Parenteral
Nutrition Nutrient Type Outlook (Revenue, USD Million, 2015 - 2026)
- Carbohydrates
- Lipid Emulsion
- Single Dose Amino
Acid Solution
- Trace Elements
- Vitamins &
Minerals
Parenteral
Nutrition Regional Outlook (Revenue, USD Million, 2015 – 2026)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Spain
- Italy
- France
- Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Middle East and
Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment